Pharmaceutical and Biotechnology Patent Life Cycles and Portfolio Strategies

American Conference Institute is Pleased to Present: Pharmaceutical and Biotechnology Patent Life Cycles and Portfolio Strategies

Wednesday, February 26 to Thursday, February 27, 2014
DoubleTree Suites Times Square, New York, NY

Pharmaceutical and Biotechnology Patent Life Cycles and Portfolio Strategies

The definitive biopharmaceutical patent prosecution strategies conference which addresses novel IP controversies in a post-Hatch-Waxman and BPCIA world

DoubleTree Suites by Hilton | February 26 – 27, 2014 | New York, NY


For over a decade, American Conference Institute’s (ACI’s) Maximizing Pharmaceutical Patent Life Cycles and Biotech Patents conferences have brought you up-to –the minute legal, regulatory, and policy information concerning small and large molecule drug products. In re-examining these events, and through listening to you, our valued delegates, we have determined that just as the pharmaceutical and biotechnology industries have evolved and are now on converging paths that these conferences should also undergo a similar  metamorphosis. In deference to the legacy of these iconic events and your revered opinion, ACI proudly presents this new program on Pharmaceutical and Biotechnology Patent Life Cycles and Portfolio Strategies.

This conference will give you a comprehensive and thorough picture of how small and large molecule products—as well as diagnostics—operate in a world not only governed by PTO and FDA-related laws and regulations, but also against the backdrop of Hatch-Waxman, BPCIA, iconoclast Supreme Court decisions affecting the future life sciences IP, and Health Care Reform. Our stellar faculty will provide you with insights and strategies relative to life cycle management, portfolio strategies, brand optimization and new product development as well as the thoughtful and targeted commentary and in-depth analysis that you have come to expect from ACI’s industry-leading life sciences IP conferences. This event will feature:

  • Focused panels on some of the most pressing IP dilemmas facing manufacturers of both small and large molecules, including: safe harbor conundrums in light Classen and Momenta; new concerns in obviousness determinations as a result of the dichotomy between the District Courts and PTO decisions in these matters; inducement and divided infringement and related carve–out controversies relative to method of use patents; and the impact of new PTO proceedings, including PGR and IPR

  • Tailored sessions bringing you the latest information biologic-centered IP controversies, including those presently impacting BLAs, biosimilars and antibodies

  • In-depth discussions on Hatch-Waxman and Orange Book concerns relative to small molecules, including new exclusivity dilemmas for combination products, and the latest fall-out from Watson/Activis

  • An in-house briefing on the future of medical diagnostics IP in the wake of Myriad and Prometheus and how these decisions may ultimately impact small and large molecules

  • A comprehensive analysis of the USPTO’s Proposed New Rules of Professional Conduct


Master Class & Boot Camp Workshops

We are also delighted to provide you with Master Class and Boot Camp workshops that will enhance your conference experience and provide you with in-depth knowledge and essential strategies in key competencies that are essential to life sciences patenting:

“First Inventor to File” Master Class: Successful Strategies for Pharmaceutical, Biopharmaceutical, and Biotechnology Patent Practitioners will help you master filing strategies under the new “first to invent” system to help ensure patent issuance for your pharmaceutical, biopharmaceutical, and biotechnology invention both here and abroad.

PTA- PTE Boot Camp: Basic Training in the Essentials of Patent Term Adjustment and Patent Term Restoration for Patent Lawyers Serving the Pharmaceutical, Biopharmaceutical, and Biotechnology Industries will offer practical solutions and in-depth instruction for everything from eligibility requirements to calculation to the application and reconsideration processes and the interplay of PTA and PTE. This event will bring you the latest legal IP strategies and tactics for successful maneuvering in the evolving pharmaceutical, biotechnology and diagnostics landscape.

Don’t delay — register now by calling 888-224-2480, faxing your registration form to 877-927-1563 or registering on-line at www.americanconference.com/BioPharmaLifeCycles.